Records containing: Herpes Zoster
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-31A Randomized, Placebo Controlled, Observer-blind, Phase IV Pragmatic Trial to Evaluate the Effect of Recombinant Zoster Vaccine (Shingrix) on Incident Dementia Diagnosis in an Older Adult Population Aged ≥76 Years in Finland
-
CLINICAL_TRIALS study record update · 2026-03-31A Phase 1, Randomized, Multicenter, Double-blind, Dose-ranging Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants 50 to 69 Years Old
-
CLINICAL_TRIALS study record update · 2026-03-31A Phase I/II Clinical Trial With Randomized, Blinded, Controlled Design to Evaluate the Safety and Immunogenicity of the Recombinant Herpes Zoster Vaccine (CHO Cell) in Healthy Populations Aged 40 Years and Older Post -Vaccination
-
CLINICAL_TRIALS study record update · 2026-03-27The Analgesic Efficacy and Safety of Oral Medications (Venlafaxine) for Prevention of Postherpetic Neuralgia in Acute Herpes Zoster
-
CLINICAL_TRIALS study record update · 2026-03-19The Analgesic Efficacy and Safety of Oral Medications (Mirogabalin) in Patients With Herpes Zoster
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-19A Multicenter, Active-controlled, Randomized, Double Blinded, Parallel, Phase II Study to Assess the Immunogenicity and Safety of CVI-VZV-001 in Healthy Adults Aged 50 Years and Above
-
CLINICAL_TRIALS study record update · 2026-03-10A Multicenter, Double-Blind, Placebo-Controlled Phase III Clinical Trial to Evaluate the Long-Term Protective Efficacy of Recombinant Herpes Zoster Vaccine (CHO Cell) in Adults Aged 40 Years and Above
-
CLINICAL_TRIALS study record update · 2026-03-09Phase 1/2 Open-label Trial of Safety and Zoster Immunogenicity Evaluation for People With HIV With CD4 Counts Under and Above 300 and Healthy Volunteers Following Shingrix Vaccination (ZEUS)
-
CLINICAL_TRIALS study record update · 2026-02-27A Reactogenicity, Safety and Immunogenicity Study of GSK's Paediatric Herpes Zoster Subunit Candidate Vaccine (PED-HZ/su) GSK143713A in Immunocompromised Paediatric Renal Transplant Recipients
-
CLINICAL_TRIALS study record update · 2026-02-25Which Is More Effective in the Treatment of Postherpetic Neuralgia: Erector Spinae Plane Block or Transcutaneous Radiofrequency?
-
CLINICAL_TRIALS study record update · 2026-02-11Postherpetic Neuralgia After Herpes Zoster and Risk of Incident Dementia: Real-World Evidence From an International Matched Cohort With Landmark Analysis
-
CLINICAL_TRIALS study record update · 2026-02-10A Randomized, Double-Blind, Controlled Phase I/II Clinical Trial to Evaluate the Safety and Immunogenicity of Different Doses of a Lyophilized Herpes Zoster Virus mRNA Vaccine in Adults Aged 40 Years and Older
-
CLINICAL_TRIALS study record update · 2026-02-03The Regulatory Mechanisms of Electroacupuncture Intervention on Immune Cells in Herpes Zoster
-
CLINICAL_TRIALS study record update · 2026-01-30The Analgesic Efficacy and Safety of Topical Patches (Loxoprofen Sodium Patch) in Patients With Herpes Zoster
-
CLINICAL_TRIALS study record update · 2026-01-30The Analgesic Efficacy and Safety of Oral Medications (Baclofen) in Patients With Herpes Zoster
-
CLINICAL_TRIALS study record update · 2026-01-27The Analgesic Efficacy and Safety of Topical Patches (Flurbiprofen Patch) in Patients With Herpes Zoster
-
CLINICAL_TRIALS study record update · 2026-01-27The Analgesic Efficacy and Safety of Oral Medications (Tulodsesvenlafaxine) in Patients With Herpes Zoster
-
CLINICAL_TRIALS study record update · 2026-01-23The Analgesic Efficacy and Safety of Oral Medications (Desvenlafaxine) in Patients With Herpes Zoster
-
CLINICAL_TRIALS study record update · 2026-01-21A Randomized, Blinded, Placebo- and Active-Controlled, Adaptive Phase 2 Study to Evaluate the Immunogenicity and Safety of SYS6017 (a Herpes Zoster mRNA Vaccine) in Healthy Participants Aged 40 Years and Above
-
CLINICAL_TRIALS study record update · 2026-01-14The Analgesic Efficacy and Safety of Oral Medications (Crisugabalin) in Patients With Herpes Zoster
-
CLINICAL_TRIALS study record update · 2026-01-02Efficacy and Safety of Brivudine in the Treatment of Herpes Zoster: A Multicenter, Randomized, Prospective Clinical Trial
-
CLINICAL_TRIALS study record update · 2025-11-12Post-marketing Commitment Safety Study of HZ/su to Evaluate Pregnancy Exposures and Outcomes in Immunodeficient or Immunosuppressed Women Between 18 and 49 Years of Age
-
CLINICAL_TRIALS study record update · 2025-11-06A Phase 1/2 Randomized, Observer-Blinded, Active-Controlled, Dose, Escalation Multicenter Trial to Evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adult Participants 50 Years of Age and Over
-
CLINICAL_TRIALS study record update · 2025-10-07A Phase 2, Randomized, Multicenter, Active-controlled, Double-blind Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of a 2-dose Regimen of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants 50 to 79 Years Old
-
CLINICAL_TRIALS study record update · 2025-09-30A Randomized, Observer-Blind, Phase 2 Study To Assess the Safety and Immunogenicity of CRV-101 Vaccine Head-To-Head With SHINGRIX® for the Prevention of Herpes Zoster in Adults Aged 50 Years and Older